Latest News about David Pidduck
Recent news which mentions David Pidduck
CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth
November 14, 2024
From Benzinga
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
August 14, 2024
From Benzinga
From Benzinga
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
March 27, 2024
From Benzinga
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
February 07, 2024
From Benzinga
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
November 14, 2023
From Benzinga
From Benzinga
MediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDA
May 15, 2023
From Benzinga
MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30%
April 13, 2023
From Benzinga
MediPharm Labs FY22 Revenue Grows Slightly To $16.3M
March 31, 2023
From Benzinga
MediPharm Labs Q2 Revenue Declines 14% YoY, Here Are The Details
August 15, 2022
Tickers
MEDIF
From Benzinga
MediPharm Labs Enters Into $4.68M Purchase Agreement For The Sale Of Australian Facility
July 11, 2022
Tickers
MEDIF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
